Influenza vaccination in patients with haematologic malignancies: Analysis of practices in 200 patients in a single center

Bulletin du Cancer

Volumn 97, Issue 4, 2010, Pages E33-E36

  Lachenal, F ^a   Sebban, C ^a   Duruisseaux, M ^a   Biron, P ^a   Blay, J Y ^a   Ghesquieres H ^a  

^a CENTRE LÉON BÉRARD   (France)

Author keywords

Chemotherapy; Infection; Lymphoid malignancies; Public health; Vaccines

Indexed keywords

INFLUENZA VACCINE; RITUXIMAB; STEROID;

ADULT; AGED; ARTICLE; CANCER PATIENT; COMORBIDITY; DRUG CONTRAINDICATION; FEMALE; FLU LIKE SYNDROME; HEMATOLOGIC MALIGNANCY; HUMAN; INFLUENZA; INFLUENZA VACCINATION; LUNG INFECTION; MAJOR CLINICAL STUDY; MALE; PHYSICIAN ATTITUDE; PROFESSIONAL KNOWLEDGE; TREATMENT REFUSAL; ADOLESCENT; AGE; BLOOD DISEASE; MIDDLE AGED; PROSPECTIVE STUDY; STATISTICS; UTILIZATION REVIEW; VACCINATION;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; FEMALE; HEMATOLOGIC NEOPLASMS; HUMANS; INFLUENZA VACCINES; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TREATMENT REFUSAL; VACCINATION; YOUNG ADULT;

EID: 85048354384     PISSN: 00074551     EISSN: 17696917     Source Type: Journal    
DOI: 10.1684/bdc.2010.1079     Document Type: Article

References (14)

1. Brydak LB, Calbecka M. Immunogenicity of influenza vaccine in patients with hemato-oncological disorders. Leuk Lymphoma 1999; 32: 369-374 (Pubitemid 29087820)
2. Brydak LB, Machala M, Centkowski P, Warzocha K, Bilinski P. Humoral response to hemagglutinin components of influenza vaccine in patients with non-Hodgkin malignant lymphoma. Vaccine 2006; 24: 6620-6623 (Pubitemid 46107150)
3. Bucalossi A, Marotta G, Galieni P, Bigazzi C, Valenzin PE, Dispensa E. Immunological response to influenza virus vaccine in B-cell chronic lymphocytic leukaemia patients. Acta Haematol 1995; 93: 56.
4. Centkowski P, Brydak L, Machala M, Kalinka-Warzocha E, Blasinska-Morawiec M, Federowicz I, et al. Immunogenicity of influenza vaccination in patients with non-Hodgkin lymphoma. J Clin Immunol 2007; 27: 339-346 (Pubitemid 46790814)
5. Cooksley CD, Avritscher EB, Bekele BN, Rolston KV, Geraci JM, Elting LS. Epidemiology and outcomes of serious influenza-related infections in the cancer population. Cancer 2005; 104: 618-628
6. Gribabis DA, Panayiotidis P, Boussiotis VA, Hannoun C, Pangalis GA. Influenza virus vaccine in B-cell chronic lymphocytic leukaemia patients. Acta Haematol 1994; 91: 115-118 (Pubitemid 24279888)
7. Holly EA, Bracci PM. Population-based study of non-Hodgkin lymphoma, histology and medical history among human immunodeficiency virus-negative participants in San Francisco. Am J Epidemiol 2003; 158: 316-327
8. Ljungman P, Avetisyan G. Influenza vaccination in haematopoietic SCT recipients. Bone Marrow Transplant 2008; 42: 637-641
9. Ljungman P, Nahi H, Linde A. Vaccination of patients with haematological malignancies with one or two doses of influenza vaccine: a randomised study. Br J Haematol 2005; 130: 96-98 (Pubitemid 40979139)
10. Monnereau A, Orsi L, Troussard X, Berthou C, Fenaux P, Marit G, et al. History of infections and vaccinations and risk of lymphoid neoplasms: does influenza immunization reduce the risk? Leukemia 2007; 21: 2075-2079
11. Oren S, Mandelboim M, Braun-Moscovici Y, Paran D, Ablin J, Litinsky I, et al. Vaccination against influenza in patients with rheumatoid arthritis: the effect of rituximab on the humoral response. Ann Rheum Dis 2008; 67: 937-941 (Pubitemid 351956654)
12. Rapezzi D, Sticchi L, Racchi O, Mangerini R, Ferraris AM, Gaetani GF. Influenza vaccine in chronic lymphoproliferative disorders and multiple myeloma. Eur J Haematol 2003; 70: 225-230 (Pubitemid 36469759)
13. Ring A, Marx G, Steer C, Harper P. Influenza vaccination and chemotherapy: a shot in the dark? Support Care Cancer 2002; 10: 462-465
14. Robertson JD, Nagesh K, Jowitt SN, Dougal M, Anderson H, Mutton K, et al. Immunogenicity of vaccination against influenza, Streptococcus pneumoniae and Haemophilus influenzae type B in patients with multiple myeloma. Br J Cancer 2000; 82: 1261-1265 (Pubitemid 30145342)